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siRNAs and miRNAs belong to an increasingly broad class of small, noncoding RNA molecules found in diverse organisms 1 . These two groups are broadly distinguished by their biogenesis pathways and their differential loading into distinct AGO complexes. siRNAs are generated in the cytoplasm and are loaded into an AGO-containing RNA-induced silencing complex (siRISC) to cleave targets with perfect complementarity. miRNAs are transcribed in the nucleus from a specific gene and are ultimately loaded into AGO-containing miRNPs (miRISC) that limit the expression of distinct mRNA targets with imperfect complementarity. Though there are clearly shared molecular features for these two processes (for example, an AGO protein and a small RNA), there are also distinct molecular features and players important both for small-RNA loading and target recognition 2 . The AGO proteins are composed of several distinct domains with partially understood functions: an N-terminal domain, a PAZ domain that contains the binding site for the 3′ end of the small RNA, a MID domain (which will be the focus of discussion in this manuscript) that contains the binding site for the 5′ end of the small RNA, and the PIWI domain that contains the catalytic center for the cleavage reaction that occurs during RNA interference (Fig. 1a) .
A number of molecular mechanisms have been proposed to account for the observed post-transcriptional control of miRNA-targeted genes, including inhibition of translation initiation or elongation coupled with promotion of mRNA decay (reviewed in ref. 3) . One previous study identified potential sequence similarities between the MID domain of the AGO protein family and the m 7 GpppG (cap)-binding domain of the eukaryotic translation-initiation factor eIF4E (ref. 4) , immediately suggesting models of regulation directly targeting the cap-dependent step of translational initiation. Indeed, a number of studies have reported connections between the cap and translational repression [5] [6] [7] [8] [9] [10] . However, a number of other studies have called into question the relevance of this observed cap binding and have argued instead that GW182 recruitment by the AGO protein is sufficient to explain miRNA-mediated repression [11] [12] [13] . Here we use purified proteins from various species as well as an in vivo Drosophila melanogaster system to provide evidence for allostery in the AGO proteins that coordinates the binding of miRNAs, the cap and potentially other ligands to promote miRNA-mediated translational repression in these systems.
RESULTS

AGO MID domain analysis reveals functional groupings
The mechanistic questions that arose from previous studies [4] [5] [6] [7] [8] [10] [11] [12] [13] prompted us to perform more extensive bioinformatic analyses on the AGO family of proteins. Sequence similarity searches with the MID domains from the Drosophila AGOs DmAgo1 and DmAgo2 returned only known members of the AGO-PIWI protein family as matches with the basic local alignment search tool (BLAST) and the position-specific iterative (PSI)-BLAST, yet those searches returned no eIF4E family members. Moreover, full alignments that included eukaryal, archaeal and bacterial homologs of the MID domain showed that phenylalanine residues proposed to be important for cap binding 4 are not universally conserved (Supplementary Fig. 1 ). We next used the Hhpred protein structure and function prediction server 14 to identify more remote homologs of the chosen protein, and we were able to identify the ligand-binding domains from a large class of bacterial proteins including the PurR and LacI transcription factors. We found that these bacterial ligand-binding domains share high structural similarity with the known structures of the AGO MID domains (Fig. 1b) , as previously noted by others 15 . Importantly, the structure of eIF4E (ref. 16) shares no similarity with the known structure of the AGO MID domain (Fig. 1c) . Based on the alignment of the DmAgo1 MID domain sequence with known AGO MID domain structures, we created a model for use in a structure-based search using the Dali server 17 . These searches confirmed the observed sequence similarity (above) with the PurR and LacI transcription factors and led to the inclusion of numerous other proteins ( Supplementary  Fig. 2a-c) . These proteins all share a common Rossmann-like fold, and many show allosteric behavior in which binding of metabolites (for example, nucleotides) in one site is coupled to functional interactions in an independent site 18 .
We next used a clustering analysis of 834 AGO-PIWI sequences using a JAVA program, the Cluster Analysis of Sequences (CLANS) 19 , which clusters the distinct sequences in three-dimensional space to reflect their relatedness. The cluster map generated for the MID domain sequences of the AGO-PIWI protein family members (with a 10 −10 P-value cutoff ) (Fig. 1d) showed a pattern strikingly similar to that previously observed for analysis of the full-length protein 20, 21 . Close examination of the MID-derived clades reveals that their sequence relatedness reflects the known divergence in functionality of these proteins rather than simply grouping them by organism. All AGO proteins proposed to be involved in translational repression (DmAgo1, Homo sapiens Ago1-4 (HsAgo1-4) and Caenorhabditis elegans Alg1 and Alg2 (CeAlg1 and CeAlg 2)) are found in a rather tight and separate cluster, whereas DmAgo2 and CeRde1, as well as many others, clearly are not included in this group. Using the same stringency cutoff (10 −10 ), neither full-length AGO sequences nor the isolated PAZ and PIWI domains separated into more than two very broad clusters ( Supplementary Fig. 3a-c) .
These computational results are striking and suggest that the MID domain is central to the functional distinctions that define the various AGO protein family members. We suggest that these groupings (shown more clearly in Supplementary Fig. 3d , representing result obtained when stringency was increased to 10 −20 ) have considerable predictive power for the assignment of function to other AGOs. Apart from the clear distinction between AGO MID domains involved in miRNA-mediated translational repression and all other AGOs, we also note, for example, that plant AGOs are grouped based on their preference for the 5′ miRNA nucleotide 22 . Notably, the clustering results do not group together all AGO proteins that can interact with the GW repeat proteins (GW182, TNRC6B, AIN-1 and Tas3), some of which are involved in translational repression (DmAgo1, HsAGO1-4, CeAlg1 and CeAlg2) whereas others are not (such as the AGOs of Saccharomyces pombe or Archaeoglobus fulgidus AGOs) 11, [23] [24] [25] [26] (Supplementary Fig. 3d ). Based on these bioinformatic results, we predicted that there might be distinctive biochemical signatures associated with these species that could be probed through in vitro and in vivo analysis.
MID domains have distinct binding-competition profiles
As a starting point, we expressed and purified MID domains from several species (Drosophila, C. elegans and H. sapiens) as MBP fusions in Escherichia coli (Supplementary Methods). These choices were guided by an interest in parsing differences between the two small-RNA pathways: the miRNA mediators (for example, DmAgo1, CeAlg1, CeAlg2 and HsAgo1-4) and the siRNA mediators (for example, DmAgo2 and CeRde1). As controls, we used DmeIF4E and the C-terminal part of the E. coli PurR transcription regulator, which contains two copies of a MID-like structural domain that binds diverse purine substrates 27 . We examined the ability of the various MID domains to bind the cap by incubating cell lysates or purified proteins with m 7 GTP-Sepharose (a partial mimic of authentic m 7 GpppG cap structure) or GTPSepharose. All of the MID domains, as well as the ligand-binding domain of PurR, were able to bind to both resins (m 7 GTP-and GTPSepharose), though with differing affinities (Fig. 2a and Supplementary  Fig. 4a ). We note that the miRNA-related AGOs (DmAgo1, CeAlg1) consistently bound more effectively to m 7 GTP-Sepharose than the siRNA-related AGOs (DmAgo2, CeRde1) or the PurR domain (Fig. 2a) . These observations are consistent with the expectation that each of these proteins would generally bind nucleotides, albeit with different relative affinities (for example, PurR would be expected to prefer A r t i c l e s A r t i c l e s purine bases relative to pyrimidines but might not discriminate against a methyl group at position 7, as previously reported 27 ). As anticipated, the binding of DmeIF4E to m 7 GTP-Sepharose was highly efficient (Supplementary Fig. 4b ) and was specifically competed by cap-related nucleotide analogs (data not shown).
We next asked whether binding to the various resins (m 7 GTP and GTP-Sepharose) could be competed by free nucleotide analogs. As anticipated, both GTP and m 7 GpppG easily competed for PurR binding to each resin (data not shown); in addition, GTP also readily competed for DmAgo2 MID binding (Fig. 2b) . These observations are consistent with the idea that for DmAgo2, m 7 GTP-Sepharose (or GTP-Sepharose) binding is mediated through the known 5′-end miRNA binding site located within the MID domain 28, 29 .
Notably, no single nucleotide tested (including GTP, GMP, GpppG and m 7 GpppG) easily competed for DmAgo1 MID binding, and in fact binding was often stimulated by the addition of these nucleotides ( Fig. 2c and Supplementary Fig. 4c,d ). CeAlg1 MID behaved similarly ( Fig. 2c and Supplementary Fig. 4d ). These data were puzzling, and we realized that they might be rationalized by the existence of two allosterically regulated nucleotide binding sites for these particular MID domains (DmAgo1 and CeAlg1). Consistent with this idea, we found in a more complete competition analysis that binding of DmAgo1 and CeAlg1 to m 7 GTP-Sepharose was only effectively blocked by simultaneous preincubation with two different nucleotides, one cap-like and the other not ( Supplementary  Fig. 4c,d ). Although it seemed obvious that one of these proposed nucleotide binding sites must correspond to the previously defined 5′ miRNA binding site 28, 29 , it was less clear what the purpose or identity of the second site might be, though earlier studies on a potential cap-binding activity of the AGO proteins were intriguing in this regard 4, 30 .
DmAgo1 cap resin binding is stimulated by miRNAs
The potential allostery and binding models were further explored in the context of full-length AGO proteins, DmAgo1 and an N-terminally truncated version of DmAgo2 (DmAgo2∆Q, missing the N-terminal glutamine-rich region), again expressed as MBP fusions in E. coli. Both proteins were functional in standard RNA cleavage assays, indicating proper folding (Supplementary Fig. 5a ). We next performed binding experiments with the same solid-phase resins (GTP-, GMP-and m 7 GTP-Sepharose), anticipating that increased specificity might now be observed in the context of the full-length proteins: we predicted that the 5′ miRNA binding site would preferentially bind the GTP-and GMP-Sepharose resins, whereas the other site might preferentially bind the m 7 GTP-Sepharose. Moreover, it seemed possible that miRNAs would be particularly effective at triggering the binding events if allostery existed.
These general trends were clearly seen when binding to these matrices was directly compared in the presence and absence of an authentic miRNA substrate (23 nucleotides in length) and cap analog (m 7 GpppG) (Fig. 2d) . DmAgo2∆Q binds poorly to m 7 GTP and binds effectively to both GTP-and GMP-Sepharose (Fig. 2d) ; we argue that this binding is through the 5′ miRNA binding site, as miRNA effectively competes for it. By contrast, DmAgo1 binds effectively to all three resins (in the case of m 7 GTP, only when a miRNA is simultaneously bound). Most significantly, the competition profiles of DmAgo1 and DmAgo2 on m 7 GTP-Sepharose are strikingly distinct from one another (Fig. 2d) . Cap analogs have no effect on DmAgo1 GTP-or GMP-Sepharose binding, whereas they readily compete with miRNAstimulated m 7 GTP-Sepharose binding. Together, these data provide strong support for the idea that the miRNA-related AGO proteins (for example, DmAgo1) have two distinct, allosterically regulated binding sites for nucleic acids, one for small RNAs and their mimics (here, GTP and GMP) and the other for cap-like species (for example, m 7 GpppG and m 7 GMP; see Supplementary Fig. 5b ). As anticipated, we see dose-dependent stimulation of m 7 GTP-Sepharose binding by miRNAs (Fig. 2e) .
Solution studies confirm allostery seen for DmAgo1
As the previous approaches provided us with a qualitative sense of allostery in DmAgo1, we were eager to test our models in more quantitative solution based binding experiments. Any allosteric model predicts that binding in either proposed site will stimulate binding in the other. To examine this, we developed filter binding assays that monitored the binding of different radiolabeled RNA substrates. First, a short miRNA substrate was labeled at its 5′ end and binding to DmAgo1 and DmAgo2∆Q was evaluated (we used bantam as a model miRNA). The miRNA bound robustly to both DmAgo1 and DmAgo2∆Q, and direct competition experiments with unlabeled RNAs of varying lengths revealed their collective preference for miRNA-length substrates (~23 nt) (Fig. 3a,b) . These data confirm A r t i c l e s that the purified AGO proteins have a small-RNA binding site with properties that match known substrates (for example, ref. 31) . These experiments were also performed using a labeled duplex RNA (with bantam hybridized to its 2′-O-methylated complement). Overall binding affinity of the duplex is higher, but the same general pattern of length dependence is observed ( Supplementary Fig. 6a,b) . The higher affinity of the duplex could have important implications for the role of allostery in triggering downstream events in the pathway. We next asked whether the binding of miRNAs to DmAgo1 and DmAgo2∆Q was stimulated (or inhibited) by free nucleotide substrates. We began with DmAgo1 and performed the binding experiment under conditions where miRNA binding is initially inefficient, and we observed approximately threefold stimulation of binding by numerous triphosphate-containing nucleotides (m 7 GpppG, GpppG, GTP) but not by the monophosphate derivative GMP or the dinucleotide derivative NAD (Fig. 3c) . At high levels of all nucleotides, including the triphosphates that stimulate binding in the putative cap site, competition with the labeled miRNA was eventually observed. Our data in this solution-based assay support the argument that the 5′ binding site has the specificity miRNA > GMP > GTP > m 7 GpppG, whereas the putative cap site has a distinct specificity, m 7 GpppG > GpppG > GTP > GMP. From a biochemical perspective, the observation that a given nucleotide can bind both sites with some affinity is not unexpected. As seen for the purified MID domain, we did not observe allosteric behavior for DmAgo2∆Q, though GMP could compete at high concentrations (Fig. 3d) . We obtained similar results for DmAgo1 and DmAgo2∆Q when we performed these same experiments with the more tightly binding duplex (Supplementary Fig. 6c,d) .
In a complementary set of experiments, we evaluated the respective binding of radiolabeled capped and uncapped mRNA species as a function of miRNA duplex concentration. Again consistent with an allosteric model, miRNA duplex (miRNA*) stimulated DmAgo1 binding to capped mRNAs by ten-fold, whereas the same RNA species had no effect on DmAgo2∆Q binding (Fig. 3e) . Moreover, the observed miRNA*-triggered stimulation of DmAgo1 binding to labeled mRNAs was more effective for capped (m 7 GpppG) mRNA species than for those initiated with either pppG or pG (Supplementary Fig. 6e) , a trend consistent with the rankings described above. Competition experiments were next performed in order to evaluate the relative affinities of a series of cap-like compounds. Various nucleotide analogs were added to the DmAgo1 binding mixture (with saturating miRNA* and 32 P-labeled capped mRNA) (Fig. 3f) . Authentic cap (m 7 GpppG) was the most effective competitor of mRNA binding, followed by GpppG, GTP and GMP.
In vivo analysis identifies potential cap site on DmAgo1
To assess the in vivo functional relevance of our in vitro observations, we used a previously developed luciferase-based reporter system, here in Drosophila S2 cells, to probe the known function of DmAgo1 in translational repression 30, 32 . In these experiments the AGO is targeted directly to the mRNA of interest through a fused binding domain (the λ N protein), allowing mutations in the AGO protein to be directly evaluated in the presence of endogenous AGO protein. As anticipated from their distinct roles in miRNA-and siRNA-mediated gene regulation 33 , DmAgo1 effectively repressed firefly luciferase expression in the tethered system, whereas DmAgo2∆Q did not (Fig. 4a) . In an initial characterization, we found that neither increasing the amount of effector (the AGO fusion protein) nor decreasing the amount of reporter (F-Luc-5boxB) had any impact on the observed extent of repression (data not shown); these data suggest that all sites on the mRNA reporter are occupied by the AGO fusion protein and that our results shed light on core functional properties of the protein.
This assay was then used to identify mutations in the MID domain that might report on the two distinct binding sites identified through in vitro biochemistry. We looked to the structurally related proteins with Rossmann-like folds for clues, as many of these proteins have two distinct allosterically regulated ligand-binding sites 18 ( Supplementary  Fig. 7 ). The first of the conserved binding sites is the known 5′-end miRNA binding site of the AGOs, located within the last αβα element of the domain (Fig. 4b) . We mutated two conserved residues, Tyr619 and Lys623 (shown in green), that stack with the first nucleotide of the guide RNA and interact with its 5′ phosphate, respectively 29 , and evaluated their effects on repression. Residue substitutions at either position (Y619L or K623E) substantially derepressed the reporter, whereas a change in both positions (YK) yielded full derepression (Fig. 4c) . These results were initially unexpected given that direct tethering of DmAgo1 to the reporter might be expected to obviate the need for miRNA binding. We propose that these results are A r t i c l e s fully consistent with the allosteric mechanism for DmAgo1 function proposed above: miRNA binding is essential for promoting interactions in a second binding site (and/or for recruiting additional proteins such as GW182) that are somehow important in specifying translational repression.
These mutants have previously been characterized in vitro, where they showed compromised binding to miRNAs and modestly reduced cleavage of mRNAs 28 . Here, when miRNAs are supplied in saturating concentrations, the YK mutant protein efficiently cleaves mRNA targets (Supplementary Fig. 8 ). These data support the argument that the proteins are folded and functional, consistent with the stable protein that we see expressed in our S2 cells (Fig. 4c) .
Further examination of potential ligand-binding sites pointed to the loop regions found at either end of the MID domain (for example, see ligands in Supplementary Fig. 7) . We took an unbiased approach and mutated strings of residues in these loops (see Supplementary Fig. 9a ). When we evaluated these mutants in the reporter assay (Supplementary Fig. 9b ), we found that only mutation of a single loop connecting the third helix and fourth β strand (residues 627-630) resulted in substantial derepression of the reporter construct. More refined mutational analysis identified a single conserved residue, Asp627 (Fig. 4b, orange) , mutation of which to a lysine fully abolished repression, whereas mutation to a like-charged glutamate mostly maintained function (Fig. 4d) . As above, in vitro cleavage assays confirmed that this variant protein (D627K) is folded and functional, though with anticipated defects in m 7 GTP-Sepharose binding (Supplementary Figs. 8 and 9c) ; this mutationally sensitive position represents a single mutation in a surface-located residue of a large protein. Because the distance between Asp627 and the 5′-end miRNA site is about 15 Å, it seems unlikely that Asp627 plays a direct role in binding of the 5′ end of the miRNA. We propose that Asp627 is found in a second site important for allostery, and potentially one that binds to mRNA caps to participate in translational repression.
Coupled interactions of DmAgo1 with cap, miRNA and GW182
To more fully define the molecular defects of the AGO variants, we evaluated their ability to bind miRNAs and the cap in cellular S2 lysates. To evaluate miRNA binding, hemagglutinin (HA)-tagged wild-type DmAgo1 (WT) and several variants were transfected and immunoprecipitated from cells, and the amount of bantam miRNA bound was assessed by northern blot 30, 34 . Although all DmAgo1 variants were expressed, the two nonrepressing DmAgo1 variants (the YK double mutant in the 5′-end miRNA site and D627K in the putative cap site) showed no detectable binding to the bantam miRNA, whereas all functional, repressing variants showed potent miRNA binding (for example, WT, K615E, D627E and K640A) (Fig. 4e) . We also included in this analysis several controls-DmAgo2∆Q (∆Q), mutations in the putative '4E' homologous phenylalanines 4 (dblA) of DmAgo1, and DmeIF4E (4E)-none of which bound miRNA effectively. These data, combined with other functional studies (our own in Supplementary  Fig. 10a and others' in ref. 30 ) and the bioinformatics studies presented here (and in ref. 35) , make clear that the AGO proteins and eIF4E are not directly related.
The same set of S2 cell-expressed AGO protein variants revealed similar trends in an m 7 GTP-Sepharose pull-down assay. Variants that are active in the tethering assay bind the m 7 GTP resin effectively (for example, WT, K615E, D627E and K640A), whereas those variants that are inactive do not (Fig. 4f) . The nonrepressing DmAgo2∆Q, the double phenylalanine DmAgo1 (dblA), and DmeIF4E (4E) serve as controls for this experiment.
In an attempt to reconcile our results with much literature surrounding the role of GW182 in repression, we examined the effects of these same mutations on binding to this protein using a co-immunoprecipitation assay in S2 cells ( Supplementary Fig. 10b) ; these data indicate that GW182 binding directly correlates with both cap and miRNA binding. The correlation that we observed A r t i c l e s in the three different in vivo-based assays was striking: variants that repressed the tethered reporter bound miRNA, cap resin and GW182, whereas variants that failed to repress translation failed to bind all three substrates. The in vitro functionality of these variant proteins (Supplementary Figs. 8 and 9c ) and the conservative nature of the residue substitutions lend weight to the importance of these results.
DISCUSSION
The computational and biochemical results presented here provide new insights into AGO function. The MID domain stands out computationally in identifying functionally relevant groupings of AGO proteins (across organismal boundaries), whereas our biochemistry results argue for functionally distinctive behavior of the AGO proteins that reports on MID domain's mechanistic features. We propose that the subclass of the AGO protein family involved in miRNA-mediated gene regulation (DmAgo1, CeAlg1, CeAlg2 and HsAgo1-HsAgo4) depends on allostery to modulate binding to at least two distinct ligands, a miRNA and an mRNA cap (Fig. 5) . Such allostery could allow this family of proteins to trigger translational repression through cap binding when loaded with a miRNA engaged on an authentic target 4, 36 . Alternatively, the allostery could be used during the miRNP loading phase in which the AGO is deciphering the miRNA-mRNA duplex in the process of target identification [37] [38] [39] . We cannot exclude the possibility that the potential cap-binding site is normally occupied by free nucleotides or other RNA species in the cell. For example, such an allosteric site might provide a route for the regulation of miRNA-mediated events during certain stages in the cell cycle 40 (correlated with cellular nucleotide levels; for example, ref. 41) or in certain cellular environments. We note that the binding affinities of DmAgo1 for free nucleotides are substantially lower than those for intact mRNA-like species, arguing against such more speculative models.
In either of the above models, effects on repression could manifest themselves through interactions with GW182 or other factors (Fig. 5) . Indeed, there is considerable evidence supporting an essential role for GW182 (and its homologs, HsTNRC6B and CeAIN-1) in mediating translational repression [11] [12] [13] 21, 42 . Moreover, a number of studies support the argument for a direct connection between miRNA loading and downstream functional consequences [42] [43] [44] , whereas some others suggest that such coupling is not essential 12, 25 . Here mutations in the 5′ miRNA binding site simultaneously abrogate GW182 and miRNA binding (and also cap binding) and in turn fail to repress target mRNA translation. From these data alone, we are unable to determine the root cause for the loss of translational repression. One recent study describes DmAgo1 mutants with impaired GW182 binding and unaffected miRNA binding that retain the ability to partially repress multiple mRNA targets 12 ; such studies leave open the possibility that both GW182 and cap binding can contribute to translational repression 6, 7 . These ideas are also consistent with recent reports 8 . A parsimonious model for these diverse results would invoke the coupling of all three elements through the AGO protein, miRNA, cap and GW182, all present in the cell at somewhat limiting concentrations, and binding of any would induce the cooperative assembly of the repressive complex (outlined hypothetically in Fig. 5 ). These ideas lead to a number of specific predictions that can be tested.
The allostery that we document is appealing for a number of reasons. First, the AGO proteins are distantly related to a large group of proteins having a Rossmann-like fold, a number of which have two distinct ligand-binding domains that are allosterically regulated 18 . A particularly interesting example is the protein PyrR that binds pyrimidine nucleotides in one site and regulates downstream transcription through interactions with an RNA structure eerily similar to that of a miRNA bound to its target 45 . Second, recent structures of Thermus thermophilus AGO show conformational changes in the MID and PIWI domains upon binding of various miRNA species [46] [47] [48] . The authors argue that rotation allows better accommodation of the guide strand between the 5′ miRNA binding site and the PIWI domains but could also affect elements in the those domains important for binding the cap and/or GW182 or other molecular players. For example, it seems plausible that a similar mechanism is in play in C. elegans, where nRDE-3 AGO redistributes from the cytoplasm to the nucleus only upon binding to siRNA 49 . Our observations provide a biochemical readout for these structural changes-allostery-and lead us to argue for the relevance of this mechanistic feature for in vivo function.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
ONLINE METHODS
Bioinformatic analysis. We collected sequences of the MID domains from AGO-PIWI family proteins using PSI-BLAST searches of the US National Center for Biotechnology Information (NCBI) NR (nonredundant) database. We used different MID domains from eukaryotic AGOs as PSI-BLAST queries (E-value cutoff = 0.001, maximum 11 rounds, NR database). We performed additional sequence-structure analysis using HHpred 14 and BioInfoBank Meta-Server 50 .
We aligned sequences of different MID domains using ClustalW 51 , HHpred and 3D-Jury 50 and adjusted them by hand using secondary structure predictions (Supplementary Fig. 1 ).
We built structure models for the DmAgo1 MID domain (GI 17647145, residues 538-665) using the alignment interface of SWISS-MODEL workspace 52 and structures of A. fulgidus PIWI domains (PDB 1W9H and PDB 2BGG 29 ) as templates. We used the Dali server 17 to perform a structure-based search on the MID domain from A. fulgidus (PDB 1W9H) (Supplementary Fig. 2a) .
We performed clustering of sequences using the Cluster Analysis of Sequences (CLANS) application 19 on the sample of sequences we collected from the PSI-BLAST searches using DmAgo1 MID, PAZ and PIWI domains. We chose a set of 834 sequences that contained all three conserved PAZ, MID and PIWI domains. These sequences were clustered in three-dimensional space for approximately 5,000 rounds using the same P-value cutoff (10 −10 ) for either full-length protein or individual domain sequences. AGO MID domains were also clustered using a P-value cutoff of 10 −20 .
Binding to m 7 GTP-, GTP-and GMP-Sepharose beads. We diluted purified MBP-MID proteins, DmeIF4E and PurR-C into 200 µl PBS with 5 mM MgCl 2 . When indicated, we added m 7 GpppG (NEB), m 7 GMP (Jena Bioscience), GpppG (NEB), GTP and GMP (Amersham) or a combination thereof to a final concentration of 500 µM. We incubated the samples for 15 min at 4 °C before addition of 30 µl m 7 GTP-(GE Healthcare), GTP-or GMP-Sepharose beads (Sigma), followed by rotation for 2 h at 4 °C. We washed the beads four times with 600 µl PBS, 2 mM MgCl 2 and heparin (0.5 mg ml -1 ) and eluted bound proteins with sample buffer. We analyzed the elutions either by colloidal Coomassie blue staining or by western blotting. For the miRNA stimulation and competition experiments, we incubated DmAgo1 and DmAgo2∆Q with saturating amounts of bantam miRNA before the binding experiment.
Labeling of RNAs.
We prepared radiolabeled bantam using T4 polynucleotide kinase (PNK) (NEB) and [γ-32 P]ATP (PerkinElmer) 53 and then purified it by denaturing PAGE. We prepared radiolabeled duplex by mixing radiolabeled bantam with antisense oligonucleotide (antagomir in ref. 54 ). We annealed the mixture and treated it with S1 nuclease (Invitrogen) to remove remaining single-stranded oligonucleotide and purified labeled duplex by native PAGE.
We prepared radiolabeled capped mRNA species according to a modified protocol (from ref. 55 We radiolabled uncapped mRNA species (pG and pppG) at 3′ ends using [ 32 P]pCp and T4 RNA ligase (Promega) according to the manufacturer's instructions and then purified the labeled RNA transcripts by denaturing PAGE.
Filter binding assays. We performed competition experiments with RNAs of several different lengths using a constant amount of the assayed protein and labeled bantam or duplex miRNA. We premixed varying amounts of nonlabeled RNA and a constant amount of labeled bantam or duplex in PBS with 5 mM MgCl 2 , then added protein and incubated the mixture at 25 ˚C for 30 min.
We performed stimulation experiments with nucleotide substrates by premixing a constant amount of assayed protein with varying amounts of nucleotide substrates, and then incubating at room temperature for 10 min. We then added labeled bantam or duplex and incubated the mixtures for an additional 30 min. We performed experiments with capped and uncapped mRNA species by premixing assayed protein with bantam or duplex and incubating the mixture at room temperature for 30 min. We then added labeled mRNA species and incubated the mixtures for an additional 10 min. Where indicated, we premixed nucleotide substrates with mRNA species. We performed filter binding assays 56 using 400 µl of assay buffer for washing steps.
